GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Invictus MD Strategies Corp (OTCPK:IVITF) » Definitions » Gross Profit

Invictus MD Strategies (Invictus MD Strategies) Gross Profit : $2.36 Mil (TTM As of Oct. 2019)


View and export this data going back to 2015. Start your Free Trial

What is Invictus MD Strategies Gross Profit?

Invictus MD Strategies's gross profit for the three months ended in Oct. 2019 was $0.19 Mil. Invictus MD Strategies's gross profit for the trailing twelve months (TTM) ended in Oct. 2019 was $2.36 Mil.

Gross Margin % is calculated as gross profit divided by its revenue. Invictus MD Strategies's gross profit for the three months ended in Oct. 2019 was $0.19 Mil. Invictus MD Strategies's Revenue for the three months ended in Oct. 2019 was $0.64 Mil. Therefore, Invictus MD Strategies's Gross Margin % for the quarter that ended in Oct. 2019 was 29.40%.

Invictus MD Strategies had a gross margin of 29.40% for the quarter that ended in Oct. 2019 => Competition eroding margins


Invictus MD Strategies Gross Profit Historical Data

The historical data trend for Invictus MD Strategies's Gross Profit can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Invictus MD Strategies Gross Profit Chart

Invictus MD Strategies Annual Data
Trend Jan15 Jan16 Jan17 Jan18 Jan19
Gross Profit
- 0.85 0.75 1.33 1.14

Invictus MD Strategies Quarterly Data
Jan15 Apr15 Jul15 Oct15 Jan16 Apr16 Jul16 Oct16 Jan17 Apr17 Jul17 Oct17 Jan18 Apr18 Jul18 Oct18 Jan19 Apr19 Jul19 Oct19
Gross Profit Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.20 0.86 0.92 0.40 0.19

Competitive Comparison of Invictus MD Strategies's Gross Profit

For the Drug Manufacturers - Specialty & Generic subindustry, Invictus MD Strategies's Gross Profit, along with its competitors' market caps and Gross Profit data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Invictus MD Strategies's Gross Profit Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Invictus MD Strategies's Gross Profit distribution charts can be found below:

* The bar in red indicates where Invictus MD Strategies's Gross Profit falls into.



Invictus MD Strategies Gross Profit Calculation

Gross Profit is the different between the sale prices and the cost of buying or producing the goods.

Invictus MD Strategies's Gross Profit for the fiscal year that ended in Jan. 2019 is calculated as

Gross Profit (A: Jan. 2019 )=Revenue - Cost of Goods Sold
=3.529 - 2.391
=1.14

Invictus MD Strategies's Gross Profit for the quarter that ended in Oct. 2019 is calculated as

Gross Profit (Q: Oct. 2019 )=Revenue - Cost of Goods Sold
=0.636 - 0.449
=0.19

Gross Profit for the trailing twelve months (TTM) ended in Oct. 2019 adds up the quarterly data reported by the company within the most recent 12 months, which was $2.36 Mil.

Gross Profit is the numerator in the calculation of Gross Margin.

Invictus MD Strategies's Gross Margin % for the quarter that ended in Oct. 2019 is calculated as

Gross Margin % (Q: Oct. 2019 )=Gross Profit (Q: Oct. 2019 ) / Revenue (Q: Oct. 2019 )
=(Revenue - Cost of Goods Sold) / Revenue
=0.19 / 0.636
=29.40 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.


Invictus MD Strategies  (OTCPK:IVITF) Gross Profit Explanation

Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.

Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %

1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key

Invictus MD Strategies had a gross margin of 29.40% for the quarter that ended in Oct. 2019 => Competition eroding margins


Invictus MD Strategies Gross Profit Related Terms

Thank you for viewing the detailed overview of Invictus MD Strategies's Gross Profit provided by GuruFocus.com. Please click on the following links to see related term pages.


Invictus MD Strategies (Invictus MD Strategies) Business Description

Traded in Other Exchanges
N/A
Address
595 Burrard Street, 16th floor, Vancouver, BC, CAN, V7X 1J1
Invictus MD Strategies Corp is a cannabis company with a focus on the Canadian cannabis space, offering a selection of products under a wide range of cannabinoid profiles that fit the demand of the company's medical clients and retail customers. Its wholly-owned subsidiary's Phase I and Phase II facilities are in full production. The company's 50% owned subsidiary has completed its Phase II expansion and received its amended license from Health Canada. Another of its wholly owned subsidiary, connects medical clients to physicians for medical cannabis.

Invictus MD Strategies (Invictus MD Strategies) Headlines

From GuruFocus

INVICTUS ANNOUNCES AB LABORATORIES INC. UPDATE

By Marketwired Marketwired 06-26-2019

INVICTUS CLOSES SALE OF 0989561 BC LTD. DBA CANANDIA BIOCEUTICALS

By Marketwired Marketwired 09-24-2019

Invictus announces Closing of Non-Brokered Private Placement

By Marketwired Marketwired 07-09-2019

ACREAGE PHARMS LTD. GRANTED OIL SALES LICENSE

By Marketwired Marketwired 08-14-2019

Invictus announces Annual General Meeting Date

By Marketwired Marketwired 06-20-2019

INVICTUS ANNOUNCES FIRST QUARTER FINANCIAL RESULTS

By Marketwired Marketwired 06-28-2019

INVICTUS ANNOUNCES AB VENTURES INC. UPDATE

By Marketwired Marketwired 07-02-2019